News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
January, 2025
January 2025
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
2728293031  
Jonathan Bohlen joins Gene Center Munich to study the role of mRNA translation in human immunity
Photo from Jonathan Bohlen/LinkedIn
Aug 3, 2024, 10:13

Jonathan Bohlen joins Gene Center Munich to study the role of mRNA translation in human immunity

Gene Center Munich shared a post on X:

”We are delighted to welcome Jonathan Bohlen to the Gene Center! Jonathan joins us as a junior research group leader, focusing his research on mRNA translation in human immunity. Details about his research.”

Jonathan Bohlen, Junior research group leader at Gene Center Munich, shared Gene Center Munich’s post on X, adding:

”It’s a very special day for me. I am so excited and grateful for this opportunity. My lab will study the role of mRNA translation in human immunity. Reach out if you’re interested to join us.”

Source: Gene Center Munich/X and Jonathan Bohlen/X

cancer Cancer research Gene Center Munich human immunity Imagine Institute of Genetic Diseases Jonathan Bohlen OncoDaily Oncology
Special Coverage
Insight
Jan 15, 2025, 03:43
Tempus AI Introduced xH: Its First Whole-Genome Sequencing Test
Insight
Jan 15, 2025, 03:32
A Study Found That Minimal Patient Distress Is Associated with Multi-Cancer Early Detection Testing
Dialogues
Jan 15, 2025, 03:27
Current and Future Research to Improve the Outcomes of Patients with Anal Cancer
Science
Jan 14, 2025, 19:05
Shaida Ouladan: Chimeric Antigen Receptor-T Cells in Colorectal Cancer
Societies
Jan 14, 2025, 19:03
Become a CancerX 2025 Accelerator Mentor
Blog
Jan 14, 2025, 18:58
Professor Tak Mak shares the story behind his discovery of the T Cell Receptor - SPCC
Science
Jan 14, 2025, 18:51
Abi Siva: Another step close to De-escalation
Science
Jan 14, 2025, 18:49
Naveen Pemmaraju: Addition of navitoclax to ruxolitinib for patients with myelofibrosis
Blog
Jan 14, 2025, 18:47
Zeena Salman: Five-year anniversary working with St. Jude Children's Research Hospital
Dialogues
Jan 14, 2025, 18:45
United by Unique: Centering Care Around People and Their Stories
Blog
Jan 14, 2025, 18:40
Anna Rathkopf: Learning about Breast Density after a cancer diagnosis
Blog
Jan 14, 2025, 18:40
GSK has announced agreement to acquire the U.S. biotech firm IDRx for up to $1.15 billion